Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/30/2003US6670327 bactericidal/ permeability-increasing protein (BPI) protein
12/30/2003US6670323 Hemoglobulin mutations for oxygen delivery
12/30/2003US6670195 Mutant genes in Familial British Dementia and Familial Danish Dementia
12/30/2003US6670188 Packaging systems for human recombinant adenovirus to be used in gene therapy
12/30/2003US6670187 Mutant Plk protein and gene encoding the same
12/30/2003US6670186 RNA-loaded antigen presenting cells
12/30/2003US6670183 88kDa tumorigenic growth factor and antagonists
12/30/2003US6670181 Compositions and methods for treating viral infections
12/30/2003US6670178 Primary or secondary cell having stably integrated into its genome: exogenous DNA that encodes a glucagon-like peptide 1 related peptide, and DNA sequences that direct expression of the exogenous DNA
12/30/2003US6670177 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus
12/30/2003US6670159 Preparing monomeric metal ion chelator containing diacetyl glycine group linked to proteinaceous molecule
12/30/2003US6670151 Porcine stem cell factor varients and recombinant cells expressing such polypeptides
12/30/2003US6670150 Isolated human receptor proteins, nucleic acid molecules encoding human receptor proteins, and uses thereof
12/30/2003US6670149 TWIK-5 potassium channel nucleic acids and uses therefor
12/30/2003US6670148 Compositions comprising bioactive peptides prepared without formation of native disulfide bonds
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6670135 Assaying the binding of a DCSema polypeptide to a VESPR protein.
12/30/2003US6670134 Identifying modulators of the receptor, especially by measuring the increase or decrease in adenylate cyclase activity.
12/30/2003US6670130 DNA molecule of an Internal Transcribed Spacer region of Mycobacterium fortuitum having a specific sequence
12/30/2003US6670123 Method for detecting hematopoietic stem cells
12/30/2003US6670119 Nucleic acid encoding a polypeptide having a specific sequence; nucleic acid expression level is lower in gastric cancer cells compared to normal gastric cells; cancer diagnosis
12/30/2003US6670114 Screening for molecules which modulate the binding between HCV and human apolipoprotein B
12/30/2003US6669963 Stable particle in liquid formulations
12/30/2003US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes
12/30/2003US6669945 Universal T-cell epitopes for anti-malarial vaccines
12/30/2003US6669943 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/30/2003US6669942 Defective adenoviruses having a genome that includes a first recombinant DNA containing a therapeutic gene and a second rcombinant DNA containing an immunoprotective gene
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6669940 For immunizing an animal against liver abscesses caused by F. necrophorum
12/30/2003US6669939 Peptide mixtures which are mimetics of kaposi sarcoma associated herpes virus (KSHV) proteins, and biological conjugates, used in kits for diagnosis or detection of antibodies or infections of DNA viruses
12/30/2003US6669938 ImmunoConjucates for cancer diagnosis and therapy
12/30/2003US6669934 Administering interleukins, cytokines, leukemia inhibitory factors, ciliary neurotrophic growth factors, oncostatins and derivatives to mammals to control pregnancy
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/30/2003CA2215727C Hybrid phthalocyanine derivatives and their uses
12/30/2003CA2163641C Multiple sclerosis virus
12/30/2003CA2140927C Platelet aggregation inhibitors
12/30/2003CA2132976C Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
12/30/2003CA2128421C Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
12/30/2003CA2090011C Anti-inflammatory factor, method of isolation, and use
12/30/2003CA2067862C Stable pura vectors and uses thereof
12/25/2003WO2003106682A1 Hla-a24-restricted cancer antigen peptide
12/25/2003WO2003106495A2 MONOCLONAL ANTIBODY hPAM4
12/25/2003US20030237117 High velocity projectile bombardment; insect resistant plants
12/25/2003US20030237112 Nuclear fertility restorer genes and methods of use in plants
12/25/2003US20030237111 Lepidopteran-active Bacillus thuringiensis delta-endotoxin polynucleotides, compositions, and methods of use
12/25/2003US20030237110 Polynucleotides and polypeptides derived from corn seedling
12/25/2003US20030237109 Flower-bud formation suppressor gene and early flowering plant
12/25/2003US20030237105 Transgenic hybrid rodents; modulation phenotype
12/25/2003US20030237102 Method of reducing neuronal electrical activity with a potassium channel subunit
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236629 Method and apparatus for calculating optimized solution of amino acid sequences of multiple-mutated proteins and storage medium storing program for executing the method
12/25/2003US20030236396 Secretory signal sequences and uses thereof
12/25/2003US20030236395 Antiproliferative agents; anticancer agents
12/25/2003US20030236393 Virulence genes of M. marinum and M. tuberculosis
12/25/2003US20030236392 Genetic engineering; polypeptide library
12/25/2003US20030236390 Materials for the production of nanometer structures and use thereof
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer
12/25/2003US20030236197 Modulators of beta-amyloid peptide aggregation
12/25/2003US20030236195 Isolated from Bacillus; for controlling Lepidotera
12/25/2003US20030236194 Novel G protein-coupled receptor, GAVE2
12/25/2003US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2
12/25/2003US20030236190 Isulin and IGF-1 receptor agonists and antagonists
12/25/2003US20030236189 Two synthetic peptides for treatment and prevention of cancers
12/25/2003US20030236188 Troponins; membrane proteins
12/25/2003US20030236186 Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin
12/25/2003US20030235915 Human-nucleic acid sequences from breast tumor tissue
12/25/2003US20030235889 Materials and methods involving conditional retention domains
12/25/2003US20030235888 Therapy for bone defects
12/25/2003US20030235887 Modulation contraction of stomach tissue; gastrointestinal disorders; applying peptide
12/25/2003US20030235885 Dna encoded hybrid protein; therapy for cystic fibrosis
12/25/2003US20030235883 Hybrid nucleic acids; cloning; complexing
12/25/2003US20030235882 Genetic engineered polypeptides; binding to antibodies
12/25/2003US20030235876 Novel Bartonella antigen lysate extracts for use in ELISA diagnostic
12/25/2003US20030235874 Expression vector comprising prostate specific enhancer sequences (PSES) and coding antiproliferative/antitumor agent for treatment of androgen-independent and androgen-dependent prostate carcinomas
12/25/2003US20030235871 Method for identifying agonists and antagonists of the GPR45-like/GPR63 receptor
12/25/2003US20030235864 Method to screen ligands using eukaryotic cell display
12/25/2003US20030235862 Methods of characterizing molecular interaction sites on proteins
12/25/2003US20030235861 Multimolecular, two-dimensional lattice or aggregate comprising immobilized cd antigens and monoclonal antibodies for monitor protein binding activity; competetive binding bioassay; treating cancer, allergies and inflammation
12/25/2003US20030235856 Oligonucleotide for detection and identification of mycobacteria
12/25/2003US20030235855 Assay for the detection of paclitaxel resistant cells in human tumors
12/25/2003US20030235853 Solid phase synthesis; for drug screening
12/25/2003US20030235852 Nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues, and methods of making same using peptide modifying agents
12/25/2003US20030235851 Fusion proteins; combinatorial libraries
12/25/2003US20030235842 Map
12/25/2003US20030235838 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
12/25/2003US20030235835 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
12/25/2003US20030235833 Guanosine triphosphate-binding protein coupled receptors
12/25/2003US20030235831 Nucleic acids, proteins, and antibodies
12/25/2003US20030235829 Nucleic acids, proteins, and antibodies
12/25/2003US20030235826 Gene and protein specific for excitable tissues
12/25/2003US20030235823 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation
12/25/2003US20030235821 Novel Human proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030235820 Detecting and identifying tumor related transcripts associated with cancer; screening and monitoring antiproliferative agents
12/25/2003US20030235818 Identifying amino acid sequences which mimic epitopes of target proteins such as shigella toxin, hepatitis viral coat protein and anthrax lethal factor for development of genetic vacines
12/25/2003US20030235815 Synthetic peptides that bind to the hepatitis B virus core and E antigens
12/25/2003US20030235594 Comprises major histocompatability complex I epitopes
12/25/2003US20030235593 Kits; vaccines
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/25/2003US20030235591 Comprises hepatitis B surface antigens
1 ... 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 ... 2916